With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Saving Lives, Saving Neurons, the Head Start Consortium for Young Children with Malignant Central Nervous System Tumors||Children's Hospital Los Angeles / Jonathan Finlay, MD||Phase I/II Infrastructure Grants||2007||California|
|Perinatal Hormonal Biomarkers and Risk of Testicular Germ Cell Tumors||University of California Berkeley / Catherine Metayer, MD, PhD||Epidemiology Grants||2014||California|
|Single Cell Signaling Profiles In High-Risk Pediatric Leukemia||Stanford University / Kara Davis||Young Investigator Grants||2010||California|
|Pediatric Developmental Therapeutics Center of Excellence at UCSF||University of California San Francisco / Katherine Matthay, MD, Kieuhoa Vo, MD, - Scholars: Amit Sabnis, MD, Lena Winestone, MD/MSHP, Beth Winger, MD/PhD, Bo Qiu, MD/PhD||Center of Excellence Grants||2012||California|
|Next-Generation Therapies for Hedgehog Pathway-Dependent Tumors||Lucile Packard Children's Hospital at Stanford University School of Medicine / James Chen, PhD||Innovation Grants||2013||California|
|Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma||University of California San Francisco / Ozlem Aksoy, PhD||Young Investigator Grants||2015||California|
|Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2018||California|
|Blockade of Mycn in neuroblastoma||University of California San Francisco / William Weiss||Innovation Grants||2008||California|
|Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells||Stanford University School of Medicine / Alice Bertaina, MD/PhD||Reach Grants||2019||California|
|GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma||Board of Trustees of the Leland Stanford Junior University / Michelle Monje||Catalyst Grants||2021||California|